Top Analyst Reports for Berkshire Hathaway, Thermo Fisher & T-Mobile Zacks.com 1 day ago
Monday, April 12, 2021
The Zacks Research Daily presents the best research output of our analyst team. Today s Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), Thermo Fisher Scientific (TMO), and T-Mobile US (TMUS). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Popular Searches
Shares of
Berkshire Hathaway have outperformed the Zacks Insurance - Property and Casualty industry over the past year (+41.7% vs. +30.5%). The Zacks analyst believes that continued insurance business growth fuels increase in float, drive earnings and generates maximum return on equity.
Thermo Fisher (TMO) Expands in Viral Vector With Henogen Buyout Zacks.com 1/18/2021
In an effort to expand its cell and gene vaccines and therapies footprint internationally,
Thermo Fisher Scientific Inc. TMO recently acquired Belgium-based Henogen S.A. Henogen is the viral vector manufacturing business of life sciences service and technology supplier, Groupe Novasep SAS.
Popular Searches
Per the financial terms of the deal, Thermo Fisher completed this acquisition for a deal value of approximately €725 million (roughly $880 million) in cash. This business will get integrated within Thermo Fisher’s Pharma Services business within the broader Laboratory Products and Services Segment.
A Glimpse of Henogen’s Business